Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1074 | Neuroendocrinology | ICEECE2012

Mechanisms for the protective effects of 17-β-estradiol: relevance to depressive symptoms in Parkinson’s disease

Kumar P. , Kale R. , Cowsik S. , Baquer N.

Background: Parkinson’s disease (PD) is a neurodegenerative disease and a movement disorder characterized by loss of dopaminergic neurons in the substantia nigra causing dopamine depletion in the striatum. Neurodegeneration in PD occurs due to multiple pathways including oxidative stress, mitochondrial damage, protein aggregation. These changes increase during menopausal condition in females when the level of estradiol is decreased. Recently, there has been a growing inte...

ea0025p70 | Clinical biochemistry | SFEBES2011

Sweating is only half the story

Amirchetty Smitha , Parkinson Craig

A 30-year-old female reported a 2-year history of excessive sweating / flushing affecting the right hand side of the face and scalp along with the right arm. These symptoms were generally related to exercise and demonstrated a sharp midline demarcation, being present only on the right hand side.Past medical history included hypothyroidism secondary to Hashimoto’s Thyroiditis. She was euthyroid on levothyroxine. She also reported unequal pupils since...

ea0015p60 | Clinical practice/governance and case reports | SFEBES2008

Hypercalcaemia: a common presentation, an interesting cause: where isolated splenomegaly and hypercalcaemia are the only features of sarcodosis

Alsabbagh Samer , Parkinson Craig

An 80-year old female was admitted to Ipswich Hospital with anorexia, constipation, thirst and fatigue. Her examination was unremarkable apart from 2 cm splenomegaly. Investigations revealed renal impairment (creatinine 293 umol/l), normal electrolytes along with hypercalcaemia (corrected Ca 3.54 mmol/l), normal PO4, normal CXR, PTH of 3.3 pmol/l (NR -normal range- 0.95–5.7 pmol/l) and protein electrophoresis was normal. Abdominal USS confirmed splenomegaly. Af...

ea0011p155 | Clinical case reports | ECE2006

Acromegaly with a double pituitary adenoma

Chandran S , Parkinson C

Although double adenomas may be present in 1% of autopsy pituitaries, in patients with pituitary disease they are extremely rare. In previously reported surgical series an incidence of 0.37–1.64% has been observed. We report a 55 year old lady with features suggestive of acromegaly and a double pituitary adenoma on MRI. The diagnosis of acromegaly was confirmed by an elevated serum IGF-I and a nadir growth hormone of 10.3 mU/l during a 75 g oral glucose tolerance test. Ot...

ea0002p33 | Diabetes and metabolism | SFE2001

NORMALISATION OF 150 kDa INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 TERNARY COMPLEX FORMATION DURING PEGVISOMANT THERAPY IN ACROMEGALY

Parkinson C , Flyvbjerg A , Trainer P

Serum IGF-I is increasingly used, and IGFBP-3 has been proposed, as a marker of treatment efficacy in patients with acromegaly. IGF-I bioactivity and half-life are dependent on the degree of IGF-I incorporation into 150kDa ternary complexes with IGFBP-3 and ALS. When serum GH is lowered in patients with acromegaly all three ternary complex components decline, but effects on ternary complex formation have not been described. We investigated GH action on ternary complex formatio...

ea0085p78 | Obesity 2 | BSPED2022

Evaluating glycaemic variations in children and young people with obesity using continuous glucose monitoring

Apperley Louise , Parkinson Jennifer , Senniappan Senthil

Introduction: Type 2 diabetes mellitus is a known complication of childhood obesity. It is currently diagnosed by undertaking an oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) is used predominantly by patients with type 1 diabetes mellitus to monitor glucose levels.Aim: The aim of the study was to investigate glycaemic variation in children and adolescents with obesity who have had no evidence of pre-diabetes or type 2 diabetes o...

ea0095oc5.8 | Oral Communications 5 | BSPED2023

Liraglutide improves metabolic profile, glycaemic dysregulation, quality-of-life and eating behaviours in adolescents with severe obesity

Apperley Louise , Parkinson Jennifer , Senniappan Senthil

Introduction: Childhood obesity is associated with various complications and medical treatment options are limited. Liraglutide, a GLP-1 receptor agonist, has shown improvement in body mass index (BMI) in clinical trials and has been licensed for clinical use in adolescents >12 years of age. The aim of our study is to evaluate the effect of liraglutide treatment on cardiometabolic variables, quality-of-life (QoL) and satiety levels in adolescents with seve...

ea0095p143 | Obesity 2 | BSPED2023

Significantly higher prevalence of glycaemic dysregulation in CYP with severe obesity as identified using CGM despite normal OGTT

Apperley Louise , Parkinson Jennifer , Senniappan Senthil

Introduction: Childhood obesity is associated with complications, such as impaired glucose tolerance and type 2 diabetes mellitus. The gold standard investigation for diagnosing glycaemic alterations is an oral glucose tolerance test (OGTT). Continuous glucose monitors (CGM) are routinely used in the management of children and young people (CYP) with type 1 diabetes mellitus. The aim of our study is to investigate whether CGM is more effective in identifying g...

ea0082p23 | Poster Presentations | SFEEU2022

A rare case of co-occurrence of autoimmune thyroid disease and Myasthenia gravis

Gaur Smriti , Ibitayo Hope , Manavalan Vijaikrishnan , Parkinson Craig

Introduction: Grave”s disease (GD) is a common cause of thyrotoxicosis, Myasthenia Gravis (MG) is less common (incidence of 3-30cases per million). Between 5-10% of patients with MG also have thyroid disease. However, only 0.14% of patients with GD having MG. Both are autoimmune diseases sharing pathophysiological mechanisms. Co-existence, although rare, is well established. MG may mimic the neuromuscular signs of GD especially if these are subtle. We report a case of a 3...

ea0091p45 | Poster Presentations | SFEEU2023

A case of hypogonadotropic hypogonadism (HH) due to CHARGE syndrome

Shazra Mariyam , Elkhateeb Nour , Park Soo-Mi , Parkinson Craig

Case history: A 26-year-old man was referred to the Endocrine Clinic due to lack of erections and infrequent shaving for 12 months. An extensive past medical history was noted, the majority of which was attributed to a diagnosis of cerebral palsy. Problems included feeding difficulties from birth with NG, followed by PEG feeding from age 3 to 20, gross motor, speech and language developmental delay, bilateral severe hearing impairment necessitating hearing aids, long sightedne...